- Glucose monitoring devices play a critical role in diabetes management by enabling continuous or point-in-time monitoring of blood glucose levels. These devices are essential for early detection, glycemic control, and prevention of diabetes-related complications. They are widely used in hospitals, home care settings, and increasingly by individuals through self-monitoring systems.
- The demand for glucose monitoring devices in Asia-Pacific is significantly driven by the rising incidence of diabetes, fueled by urbanization, sedentary lifestyles, and aging populations. Technological advancements such as continuous glucose monitoring (CGM) systems and integration with mobile health applications are also contributing to the shift toward proactive and personalized diabetes management.
- China is expected to be the fastest-growing region with a share of 36.4% in the Asia-pacific glucose monitoring devices market during the forecast period. This growth is supported by rapid healthcare infrastructure development, increasing affordability of advanced diagnostic tools, government initiatives for diabetes awareness and screening, and a large undiagnosed diabetic population in countries such as India and China.
- The continuous glucose monitoring (CGM) segment of 34.5% is expected to be the highest-growing segment in the Asia-Pacific glucose monitoring devices market. This is due to its ability to provide real-time data, reduce the frequency of finger pricks, and improve glycemic control. CGM adoption is accelerating, particularly in urban centers, due to its advantages in diabetes management and rising physician and patient awareness.
- China and India are expected to lead regional growth due to their large diabetic populations and increasing investments in healthcare technology. Japan, South Korea, and Australia also contribute significantly due to high health consciousness, early adoption of medical technologies, and well-established healthcare systems.
